Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.077 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |